Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy J Grizzle

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Clinical Therapeutics|March 1, 2011
Contemporary pharmacologic treatments for spasticity of the upper limb after stroke: a systematic reviewEleanor L Olvey, Edward P Armstrong, Amy J Grizzle
Open Forum Infectious Diseases|February 12, 2021
Clinical and Economic Burden of Valley Fever in Arizona: An Incidence-Based Cost-of-Illness AnalysisAmy J Grizzle, Leslie Wilson, David E Nix, et al.
Journal of Managed Care Pharmacy : JMCP|November 14, 2003
Industry's perception of presenting pharmacoeconomic models to managed care organizationsBridget M Olson, Edward P Armstrong, Amy J Grizzle, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|October 26, 2022
Cost of illness of stage IV non-small cell lung cancer (NSCLC) positive for programmed cell death ligand 1 (PD-L1) in the USJoshua E Kessler, Kwon N Park, Amy J Grizzle, et al.
Journal of Managed Care & Specialty Pharmacy|March 26, 2016
Accepting Medication Therapy Management Recommendations to Add ACEIs or ARBs in Diabetes CareJason T Hurwitz, Amy J Grizzle, Jill Augustine, et al.
Oncology and Therapy|May 13, 2022
Cost-Effectiveness of PD-L1 Testing in Non-Small Cell Lung Cancer (NSCLC) Using In Vitro Diagnostic (IVD) Versus Laboratory-Developed Test (LDT)Jason T Hurwitz, Shannon Vaffis, Amy J Grizzle, et al.
Journal of Managed Care Pharmacy : JMCP|November 19, 2004
Longitudinal analysis of the use of etanercept versus infliximab determined from medical chart auditJacob Abarca, Daniel C Malone, Edward P Armstrong, et al.
Journal of the American Pharmacists Association : Japha|May 11, 2011
Assessment tool for pharmacy drug-drug interaction softwareTerri L Warholak, Lisa E Hines, Kim R Saverno, et al.
Journal of Managed Care & Specialty Pharmacy|June 29, 2021
Cost-effectiveness of once-daily vs twice-daily tacrolimus among Hispanic and Black kidney transplant recipientsJason T Hurwitz, Amy J Grizzle, Carmelina S Tyler, et al.
Journal of Biomedical Informatics|December 16, 2019
Testing the face validity and inter-rater agreement of a simple approach to drug-drug interaction evidence assessmentAmy J Grizzle, Lisa E Hines, Daniel C Malone, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Clinical Therapeutics|March 1, 2011
Contemporary pharmacologic treatments for spasticity of the upper limb after stroke: a systematic reviewEleanor L Olvey, Edward P Armstrong, Amy J Grizzle
Open Forum Infectious Diseases|February 12, 2021
Clinical and Economic Burden of Valley Fever in Arizona: An Incidence-Based Cost-of-Illness AnalysisAmy J Grizzle, Leslie Wilson, David E Nix, et al.
Journal of Managed Care Pharmacy : JMCP|November 14, 2003
Industry's perception of presenting pharmacoeconomic models to managed care organizationsBridget M Olson, Edward P Armstrong, Amy J Grizzle, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|October 26, 2022
Cost of illness of stage IV non-small cell lung cancer (NSCLC) positive for programmed cell death ligand 1 (PD-L1) in the USJoshua E Kessler, Kwon N Park, Amy J Grizzle, et al.
Journal of Managed Care & Specialty Pharmacy|March 26, 2016
Accepting Medication Therapy Management Recommendations to Add ACEIs or ARBs in Diabetes CareJason T Hurwitz, Amy J Grizzle, Jill Augustine, et al.
Oncology and Therapy|May 13, 2022
Cost-Effectiveness of PD-L1 Testing in Non-Small Cell Lung Cancer (NSCLC) Using In Vitro Diagnostic (IVD) Versus Laboratory-Developed Test (LDT)Jason T Hurwitz, Shannon Vaffis, Amy J Grizzle, et al.
Journal of Managed Care Pharmacy : JMCP|November 19, 2004
Longitudinal analysis of the use of etanercept versus infliximab determined from medical chart auditJacob Abarca, Daniel C Malone, Edward P Armstrong, et al.
Journal of the American Pharmacists Association : Japha|May 11, 2011
Assessment tool for pharmacy drug-drug interaction softwareTerri L Warholak, Lisa E Hines, Kim R Saverno, et al.
Journal of Managed Care & Specialty Pharmacy|June 29, 2021
Cost-effectiveness of once-daily vs twice-daily tacrolimus among Hispanic and Black kidney transplant recipientsJason T Hurwitz, Amy J Grizzle, Carmelina S Tyler, et al.
Journal of Biomedical Informatics|December 16, 2019
Testing the face validity and inter-rater agreement of a simple approach to drug-drug interaction evidence assessmentAmy J Grizzle, Lisa E Hines, Daniel C Malone, et al.
Pageof 3